维普期刊资源整合服务平台（V6.5）

54篇 您的检索式：作者名="Maraninchi"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group显示文摘	Marry M Cognetti F Maraninchi D	2005	J Clin Oncol2005，23，19：	1
2	Randomized phase Ⅱ trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor 2-positive metastatic breast cancer administered as first-line treatment:the M77001 study group显示文摘	Marty M Cognetti F Maraninchi D	2005	J Clin Oncol2005，23，19：	1
3	Randomized phase Ⅱ trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment:the M77001 study group显示文摘	Marty M Coguetti F Maraninchi D		0，，19：	1
4	Randomized phase Ⅱ trial of the efficacy and safety of trastuzumab combined with do- cetaxel in patients with human epidermal growth factor receptor 2- positive metastatic breast cancer administered as first-line treat- ment: The M77001 study group 显示文摘	Marry M Cognetti F Maraninchi D	2005	J Clin Oncol2005，23，19：	1
5	Trastuzumab (lderceptin) plus docetaxel versus docetaxel alone as first line treatment of HER2-positive me- tastatic breast cancer (MBC) : results of a randomised muhicentre trial显示文摘	SExtra JM Cognetti F Maraninchi D et at	2004	Eur J Cancer2004，，12：	1
6	Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: The M77001 study group 显示文摘	Marty M Cognetti F Maraninchi D	2005	J Clin Oncol2005，3，：	1
7	Randomized phase Htrial of the efficacy and safety of trastuzumab combined withdocetaxel in patients with human epidermal growth factor receptor2-positive metastatic breast cancer administered as first-linetreatment : the M77001 study group 显示文摘	Marty M Cognetti F Maraninchi D	2005	J Clin Oncol2005，23，42：	1
8	Obesityassociated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii显示文摘	MILLION M MARANINCHI M HENRY M	2012	International Journal of Obesity2012，36，6：	1
9	Capecitabine plus docetaxel combination therapy 显示文摘	Verma S Maraninchi D O'Shaughnessy J	2005	Cancer2005，103，12：	1
10	Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2 - positive metastatic breast cancer administered, as first-line treatment: The M77001 study group 显示文摘	Marty M Cognetti F Maraninchi D	2005	J Clin Oncol2005，23，19：	1
11	Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii显示文摘	Million M Maraninchi M Henry M		0，，：	1
12	Randomized phase Ⅱ trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment:the M77001 study group显示文摘	Marty M Cognetti F Maraninchi D	2005	J Clin Oncol2005，23，19：	1
13	A phase Ⅱ study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia显示文摘	Maraninchi D Vey N Viens P	1998	Leuk Lymphoma1998，31，34：	1
14	Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group显示文摘	Marry M Cognetti F Maraninchi D	2005	J Clin Oncol2005，23，19：	1
15	Randomized phase Ⅱ trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group显示文摘	Marty M Cognetti F Maraninchi D	2005	J Clin Oncol2005，25，19：	1
16	Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in pa- tients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group显示文摘	Marty M Cognetti F Maraninchi D	2005	J Clin Oneol2005，23，19：	1
17	Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment : the M77001 Study Group 显示文摘	Marry M Cognetti F Maraninchi D	2005	J Clin Oncol2005，23，19：	1
18	Randomized phase Ⅱ trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2- positive metastatic breast cancer administered as first-line treatment : the M77001 study group 显示文摘	Marty M Cognetti F Maraninchi D	2005	J Clin Oncol2005，23，19：	1
19	Randomized phase I1 trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatmem: the M77001 study group 显示文摘	Marty M Cognetti F Maraninchi D	2005	J Clin Oncol2005，23，19：	1
20	Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor2-positive metastatic breast cancer administered as first-line treatment:the M77001 study group显示文摘	Marty M Cognetti F Maraninchi D	2005	J Clin Oncol2005，23，19：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示